A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations
We are pleased to announce the official endorsement by Ontario Health-Cancer Care Ontario (OH-CCO) of the 2023 International Stereotactic Radiosurgery Society’s Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations, published in the IJROBP – The Red Journal as open access
“The ISRS guidelines provided a ready-made, high-quality, evidence-based solution that allowed us to move quickly to meet identified patient needs” said Dr. Sunit Das, MD PhD.
For OH-CCO, this guideline endorsement is to provide clinicians with evidence-based recommendations on the management of a complex patient population presenting with symptomatic brain radiation necrosis after stereotactic radiosurgery in Ontario. This endorsed guideline will help improve the quality of patient care by providing an evidence-based approach for healthcare providers to follow.
Dr.Arjun Sahgal, President of ISRS, shared this exciting news on LinkedIn.
“Ontario Health-Cancer Care Ontario takes a step towards further improving and standardizing the management of brain necrosis following stereotactic radiosurgery, by endorsing the International Stereotactic Radiosurgery Society (ISRS) guideline published in the IJROBP – The Red Journal as open access. I couldn’t be more proud and grateful to my province of Ontario for this step forward.”
See the abstract from OH-CCO, as well as the full endorsement and quality initiative report:
To review all ISRS Guidelines, see our complete library of Clinical Practice Guidelines here:
